Comparison of the effectiveness of medicinal leech and TENS therapy in the treatment of primary osteoarthritis of the knee: A randomized controlled trial
RCT published in Zeitschrift für Rheumatologie (2017)
Abstract
OBJECTIVES: The aim of this study was to evaluate the effects of leech therapy in the treatment of knee osteoarthritis in terms of duration of effectiveness and symptom relief and to compare these results with transcutaneous electrical nerve stimulation (TENS) therapy. MATERIAL AND METHODS: This study was designed as a prospective, single center, randomized, single-blind and parallel group study. A total of 90 patients were included in the study, 46 in the leech group and 44 in the TENS group. Primary outcome measures were changes of the pain scores in visual analogue scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) on the measurements day 0, 21 and 180. Secondary outcome measures were the changes in the sub-groups of the WOMAC scores. Five leeches were applied to the affected knee, once every week for 3 weeks. RESULTS: The VAS pain score showed a similar decrease in both groups in the evaluation on day 21 (p < 0.001). The course of the change of the VAS pain score in both groups was similar in the comparisons between groups. Long-term benefits of the TENS therapy group were slightly more than the leech therapy group. All the sub-scores of WOMAC in both therapy groups showed a similar decrease (p = 0.819). Throughout the study this decrease was statistically significant in both groups (p < 0.001). CONCLUSION: Leech therapy relieves symptoms in patients with osteoarthritis of the knee and is as effective as TENS therapy in the management of osteoarthritis of the knee. This treatment has the potential of being an additional or alternative therapy for the non-surgical management of osteoarthritis of the knee.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
Randomized comparison of leech therapy (n=46) versus TENS (n=44) for primary knee osteoarthritis demonstrates similar significant VAS pain and WOMAC reductions at days 21 and 180, validating leech therapy as effective alternative.
Warum dies für die Hirudotherapie relevant ist
Diese prospektive, monozentrische, randomisierte, einfach verblindete Parallelgruppenstudie verglich die Blutegeltherapie (5 Blutegel, einmal wöchentlich über 3 Wochen am betroffenen Knie appliziert) mit TENS-Therapie bei 90 Patienten mit Kniearthrose unter Verwendung von VAS- und WOMAC-Scores an den Tagen 0, 21 und 180. Beide Gruppen zeigten ähnliche statistisch signifikante Abnahmen der VAS-Schmerzwerte und der WOMAC-Subscores, wobei TENS einen geringfügig größeren Langzeitnutzen zeigte. Dies ist für die ASH unmittelbar relevant als kontrollierte Studie, die die symptomatische Wirksamkeit der Blutegeltherapie bei Kniearthrose belegt. Die ehrliche Einschränkung besteht darin, dass die beiden Modalitäten annähernd vergleichbare Ergebnisse zeigten statt einer Überlegenheit der Blutegeltherapie, die klinische Dauerhaftigkeit über sechs Monate hinaus nicht adressiert wird und die Wirkmechanismen nicht untersucht werden.
Zitation
Comparison of the effectiveness of medicinal leech and TENS therapy in the treatment of primary osteoarthritis of the knee: A randomized controlled trial.
Isik M, Ugur M, Yakisan RS, Sari T, Yilmaz N · Zeitschrift fur Rheumatologie, 2017
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: May 26, 2026 · Letzte Aktualisierung der Website: 18. Juni 2026